Royal Bank of Canada’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57B Sell
4,471,445
-233,485
-5% -$83.2M 0.28% 68
2025
Q4
$1.54B Buy
4,704,930
+174,362
+4% +$55.3M 0.25% 72
2025
Q3
$1.28B Sell
4,530,568
-5,971
-0.1% -$1.73M 0.21% 84
2025
Q2
$1.27B Sell
4,536,539
-346,595
-7% -$98.2M 0.23% 83
2025
Q1
$1.52B Sell
4,883,134
-197,912
-4% -$58.4M 0.32% 65
2024
Q4
$1.32B Buy
5,081,046
+281,782
+6% +$83.6M 0.26% 78
2024
Q3
$1.55B Sell
4,799,264
-223,400
-4% -$73.1M 0.32% 66
2024
Q2
$1.57B Sell
5,022,664
-372,174
-7% -$109M 0.36% 58
2024
Q1
$1.53B Sell
5,394,838
-436,786
-7% -$128M 0.35% 61
2023
Q4
$1.68B Buy
5,831,624
+751,947
+15% +$205M 0.39% 49
2023
Q3
$1.37B Buy
5,079,677
+518,689
+11% +$129M 0.37% 58
2023
Q2
$1.01B Buy
4,560,988
+327,323
+8% +$76M 0.27% 80
2023
Q1
$1.02B Sell
4,233,665
-1,866,161
-31% -$458M 0.29% 72
2022
Q4
$1.6B Buy
6,099,826
+2,143
+0% +$574K 0.46% 44
2022
Q3
$1.37B Buy
6,097,683
+75,721
+1% +$18.4M 0.43% 43
2022
Q2
$1.47B Buy
6,021,962
+1,641,374
+37% +$402M 0.43% 43
2022
Q1
$1.06B Buy
4,380,588
+117,644
+3% +$27M 0.26% 80
2021
Q4
$959M Buy
4,262,944
+340,736
+9% +$71.9M 0.22% 99
2021
Q3
$834M Sell
3,922,208
-206,162
-5% -$47.5M 0.22% 98
2021
Q2
$1.01B Sell
4,128,370
-120,546
-3% -$29.7M 0.27% 80
2021
Q1
$1.06B Buy
4,248,916
+190,835
+5% +$45.5M 0.31% 69
2020
Q4
$933M Buy
4,058,081
+348,286
+9% +$80.3M 0.27% 83
2020
Q3
$943M Buy
3,709,795
+111,149
+3% +$27.5M 0.34% 67
2020
Q2
$849M Sell
3,598,646
-162,592
-4% -$37.1M 0.34% 67
2020
Q1
$763M Sell
3,761,238
-170,575
-4% -$37.3M 0.37% 60
2019
Q4
$948M Sell
3,931,813
-132,201
-3% -$29.1M 0.34% 62
2019
Q3
$786M Buy
4,064,014
+100,946
+3% +$19.4M 0.31% 67
2019
Q2
$730M Buy
3,963,068
+125,179
+3% +$22.4M 0.29% 69
2019
Q1
$729M Buy
3,837,889
+197,624
+5% +$37.7M 0.31% 69
2018
Q4
$709M Sell
3,640,265
-33,613
-0.9% -$6.56M 0.34% 60
2018
Q3
$761M Buy
3,673,878
+157,293
+4% +$31M 0.32% 64
2018
Q2
$649M Buy
3,516,585
+159,931
+5% +$28.3M 0.29% 68
2018
Q1
$572M Buy
3,356,654
+256,715
+8% +$47.1M 0.26% 73
2017
Q4
$539M Buy
3,099,939
+228,312
+8% +$40.4M 0.24% 84
2017
Q3
$535M Sell
2,871,627
-55,210
-2% -$9.78M 0.26% 76
2017
Q2
$504M Sell
2,926,837
-529,792
-15% -$86.2M 0.26% 76
2017
Q1
$567M Buy
3,456,629
+893,514
+35% +$148M 0.31% 66
2016
Q4
$375M Sell
2,563,115
-150,546
-6% -$22.7M 0.2% 84
2016
Q3
$453M Buy
2,713,661
+192,644
+8% +$32.6M 0.26% 67
2016
Q2
$384M Buy
2,521,017
+764,525
+44% +$119M 0.23% 80
2016
Q1
$263M Buy
1,756,492
+30,975
+2% +$4.6M 0.16% 101
2015
Q4
$280M Buy
1,725,517
+343,510
+25% +$54M 0.18% 93
2015
Q3
$191M Sell
1,382,007
-190,156
-12% -$30M 0.14% 112
2015
Q2
$241M Buy
1,572,163
+110,842
+8% +$17.8M 0.17% 95
2015
Q1
$234M Sell
1,461,321
-939,608
-39% -$148M 0.16% 92
2014
Q4
$382M Buy
2,400,929
+127,252
+6% +$19.8M 0.25% 66
2014
Q3
$319M Buy
2,273,677
+826,425
+57% +$108M 0.22% 75
2014
Q2
$171M Buy
1,447,252
+14,916
+1% +$1.73M 0.12% 127
2014
Q1
$177M Sell
1,432,336
-23,457
-2% -$2.84M 0.13% 111
2013
Q4
$166M Buy
1,455,793
+139,999
+11% +$15.9M 0.12% 129
2013
Q3
$147M Buy
1,315,794
+228,214
+21% +$24.7M 0.11% 128
2013
Q2
$107M Buy
+1,087,580
New +$113M 0.09% 151

Other funds holding AMGN

Royal Bank of Canada's AMGN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Amgen (AMGN) stake by 5% in Q1 2026, selling an estimated $83.2M and leaving 4,471,445 shares worth $1.57B. The position accounts for 0.28% of the portfolio, ranked #68.

Royal Bank of Canada first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.68B in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Royal Bank of Canada held 4,471,445 shares of Amgen worth $1.57B as of Q1 2026.
  • Royal Bank of Canada sold 233,485 Amgen shares in Q1 2026, an estimated $83.2M.
  • Amgen made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #68 holding.
  • Royal Bank of Canada first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Amgen position peaked at $1.68B in Q4 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.